149 related articles for article (PubMed ID: 36479633)
21. Prognostic Value of DEPDC1 Expression in Tumor and Non-tumor Tissue of Patients With Hepatocellular Carcinoma.
Amisaki M; Yagyu T; Uchinaka EI; Morimoto M; Hanaki T; Watanabe J; Tokuyasu N; Sakamoto T; Honjo S; Fujiwara Y
Anticancer Res; 2019 Aug; 39(8):4423-4430. PubMed ID: 31366540
[TBL] [Abstract][Full Text] [Related]
22. Long noncoding RNA KTN1 antisense RNA 1exerts an oncogenic function in lung adenocarcinoma by regulating DEP domain containing 1 expression via activating epithelial-mesenchymal transition.
Li YY; Li W; Chang GZ; Li YM
Anticancer Drugs; 2021 Jun; 32(6):614-625. PubMed ID: 33491970
[TBL] [Abstract][Full Text] [Related]
23. Circ-0003998 promotes cell proliferative ability and invasiveness by binding to miR-197-3p in osteosarcoma.
Wang L; Du ZG; Huang H; Li FS; Li GS; Xu SN
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10638-10646. PubMed ID: 31858530
[TBL] [Abstract][Full Text] [Related]
24. DEPDC1 is a novel cell cycle related gene that regulates mitotic progression.
Mi Y; Zhang C; Bu Y; Zhang Y; He L; Li H; Zhu H; Li Y; Lei Y; Zhu J
BMB Rep; 2015 Jul; 48(7):413-8. PubMed ID: 25902835
[TBL] [Abstract][Full Text] [Related]
25. MAFB Promotes Cancer Stemness and Tumorigenesis in Osteosarcoma through a Sox9-Mediated Positive Feedback Loop.
Chen Y; Wang T; Huang M; Liu Q; Hu C; Wang B; Han D; Chen C; Zhang J; Li Z; Liu C; Lei W; Chang Y; Wu M; Xiang D; Chen Y; Wang R; Huang W; Lei Z; Chu X
Cancer Res; 2020 Jun; 80(12):2472-2483. PubMed ID: 32234710
[TBL] [Abstract][Full Text] [Related]
26. CBX2 is a functional target of miRNA let-7a and acts as a tumor promoter in osteosarcoma.
Han Q; Li C; Cao Y; Bao J; Li K; Song R; Chen X; Li J; Wu X
Cancer Med; 2019 Jul; 8(8):3981-3991. PubMed ID: 31150156
[TBL] [Abstract][Full Text] [Related]
27. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
[TBL] [Abstract][Full Text] [Related]
28. SIRT1 enhances oxaliplatin resistance in colorectal cancer through microRNA-20b-3p/DEPDC1 axis.
Zhao B; Wang Y; Zhao X; Ni J; Zhu X; Fu Y; Yang F
Cell Biol Int; 2022 Dec; 46(12):2107-2117. PubMed ID: 36200529
[TBL] [Abstract][Full Text] [Related]
29. Long non-coding RNA PVT1 promotes osteosarcoma development by acting as a molecular sponge to regulate miR-195.
Zhou Q; Chen F; Zhao J; Li B; Liang Y; Pan W; Zhang S; Wang X; Zheng D
Oncotarget; 2016 Dec; 7(50):82620-82633. PubMed ID: 27813492
[TBL] [Abstract][Full Text] [Related]
30. Phosphorylation of DEPDC1 at Ser110 is required to maintain centrosome organization during mitosis.
Chen D; Ito S; Hyodo T; Asano-Inami E; Yuan H; Senga T
Exp Cell Res; 2017 Sep; 358(2):101-110. PubMed ID: 28602627
[TBL] [Abstract][Full Text] [Related]
31. miR-363 acts as a tumor suppressor in osteosarcoma cells by inhibiting PDZD2.
He F; Fang L; Yin Q
Oncol Rep; 2019 May; 41(5):2729-2738. PubMed ID: 30896877
[TBL] [Abstract][Full Text] [Related]
32. Long Noncoding RNA HCG9 Promotes Osteosarcoma Progression through RAD51 by Acting as a ceRNA of miR-34b-3p.
Wang L; Li S; Qi L; Ling L
Mediators Inflamm; 2021; 2021():9978882. PubMed ID: 34456631
[TBL] [Abstract][Full Text] [Related]
33. PAI-1, a target gene of miR-143, regulates invasion and metastasis by upregulating MMP-13 expression of human osteosarcoma.
Hirahata M; Osaki M; Kanda Y; Sugimoto Y; Yoshioka Y; Kosaka N; Takeshita F; Fujiwara T; Kawai A; Ito H; Ochiya T; Okada F
Cancer Med; 2016 May; 5(5):892-902. PubMed ID: 26817521
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory effect of MSH6 gene silencing in combination with cisplatin on cell proliferation of human osteosarcoma cell line MG63.
Liu HC; Zeng J; Zhang B; Liu XQ; Dai M
J Cell Physiol; 2019 Jun; 234(6):9358-9369. PubMed ID: 30456894
[TBL] [Abstract][Full Text] [Related]
35. High Expression of N-Acetylgalactosaminyl-transferase 1 (GALNT1) Associated with Invasion, Metastasis, and Proliferation in Osteosarcoma.
Zhang L; Lv B; Shi X; Gao G
Med Sci Monit; 2020 Dec; 26():e927837. PubMed ID: 33284788
[TBL] [Abstract][Full Text] [Related]
36. MiR-363 suppresses cell migration, invasion, and epithelial-mesenchymal transition of osteosarcoma by binding to NOB1.
Zhang Y; Wang F; Wang L; Zhang Q
World J Surg Oncol; 2020 May; 18(1):83. PubMed ID: 32357945
[TBL] [Abstract][Full Text] [Related]
37. Preliminary screening of differentially expressed genes involved in methyl-CpG-binding protein 2 gene-mediated proliferation in human osteosarcoma cells.
Meng G; Li Y; Lv Y; Dai H; Zhang X; Guo QN
Tumour Biol; 2015 Apr; 36(4):3009-15. PubMed ID: 25613065
[TBL] [Abstract][Full Text] [Related]
38. Cell-permeable peptide DEPDC1-ZNF224 interferes with transcriptional repression and oncogenicity in bladder cancer cells.
Harada Y; Kanehira M; Fujisawa Y; Takata R; Shuin T; Miki T; Fujioka T; Nakamura Y; Katagiri T
Cancer Res; 2010 Jul; 70(14):5829-39. PubMed ID: 20587513
[TBL] [Abstract][Full Text] [Related]
39. Up-regulation of microRNA-496 suppresses proliferation, invasion, migration and in vivo tumorigenicity of human osteosarcoma cells by targeting eIF4E.
Qi NN; Tian S; Li X; Wang FL; Liu B
Biochimie; 2019 Aug; 163():1-11. PubMed ID: 30998968
[TBL] [Abstract][Full Text] [Related]
40. DEP domain containing 1 is a novel diagnostic marker and prognostic predictor for hepatocellular carcinoma.
Yuan SG; Liao WJ; Yang JJ; Huang GJ; Huang ZQ
Asian Pac J Cancer Prev; 2014; 15(24):10917-22. PubMed ID: 25605201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
